查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
一次性生物反应器市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按产品、类型、细胞类型、分子、按应用、用途、最终用户、地区和竞赛
市场调查报告书
商品编码
1326512

一次性生物反应器市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按产品、类型、细胞类型、分子、按应用、用途、最终用户、地区和竞赛

Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Type, By Type of Cell, By Molecule, By Application, By Usage, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球一次性生物反应器市场在 2024-2028 年预测期内復合年增长率将稳定增长。这可以归因于研发（R＆D）活动、合作和战略伙伴关係的不断增加，以及对新疫苗、治疗方法和慢性病和传染病的不断增加的需求的飙升。此外，单克隆抗体的不断发展预计将创造对用于生产设施的 SUB 的需求，从而推动细分市场的增长。 2022 年1 月，HaemaLogiX Ltd (HaemaLogiX) 和Lonza 达成协议，生产HaemaLogiX 的领先多发性骨髓瘤候选药物和KappaMab 的下一个临床批次(cGMP)，KappaMab 是一种单克隆抗体，与细胞表面靶标结合，称为kappa 骨髓瘤抗原 (KMA) 存在于骨髓瘤癌细胞上，而非正常浆细胞上。

对生物製药的需求不断增加

生物製药在推动全球一次性生物反应器市场的增长方面发挥着重要作用。生物製药是利用细菌、酵母或哺乳动物细胞等活生物体生产的药物和疫苗。一次性生物反应器因其成本效益、效率和灵活性而被广泛用于这些生物製药的生产。对生物製药的需求不断增长是一次性生物反应器市场的主要驱动力之一。生物製药已成为现代医学的重要组成部分，为各种疾病提供针对性和个性化的治疗。在人口老龄化、慢性病患病率上升以及对创新和靶向治疗的需求等因素的推动下，全球生物製药市场预计将以显着的速度增长。与传统不銹钢生物反应器相比，一次性生物反应器具有多种优势，例如较低的资本和运营成本、降低的交叉污染风险以及更大的灵活性。这些优点使一次性生物反应器成为生产生物製药的有吸引力的选择，特别是对于小批量和临床试验。生物製药行业正在采用新的生物加工技术，例如高密度细胞培养和连续製造，这需要灵活高效的生物反应器。一次性生物反应器可以适应不断变化的工艺要求，使其成为这些新技术的理想选择。

一次性生物反应器的成本效益和效率

成本效益和效率是推动全球一次性生物反应器市场增长的关键因素。一次性生物反应器在成本和效率方面比传统不銹钢生物反应器具有多种优势。一次性生物反应器的主要优点之一是其较低的资本成本。传统的不銹钢生物反应器需要在基础设施和设备方面进行大量的前期资本投资，而一次性生物反应器需要的资本投资要少得多。这使得一次性生物反应器成为中小型公司以及用于降低资本成本的研发目的的有吸引力的选择；与传统生物反应器相比，一次性生物反应器的运营成本更低。使用一次性组件（例如袋子、过滤器和传感器）可以减少清洁和消毒的需要，而清洁和消毒可能既耗时又昂贵。这降低了批次之间交叉污染的风险，确保更高的质量和更一致的产品。一次性生物反应器提供更大的灵活性，从而提高效率。它们可以快速、轻鬆地设置，从而缩短产品周转时间。一次性生物反应器更能适应工艺要求的变化，使其成为研究和开发以及小规模生产的理想选择。

日益关注个性化医疗

个性化医疗是全球一次性生物反应器市场增长的主要驱动力。个性化医疗是一种医疗保健方法，在为患者设计治疗计划时考虑基因、环境和生活方式的个体差异。这种方法需要生产有针对性的个体化疗法，这可以使用生物製药和一次性生物反应器来实现。使用一次性生物反应器可以更高效、更具成本效益地生产生物药品，这是个性化医疗的基础。与传统不銹钢生物反应器相比，一次性生物反应器在灵活性、效率和可扩展性方面具有多种优势，使其成为生产靶向和个性化疗法的理想选择。

生物加工技术的进步

技术和研究的进步是全球一次性生物反应器市场增长的关键驱动力。随着生物製药行业的不断发展和扩张，对更高效、更具成本效益的生物加工解决方案的需求日益增长。新材料和製造工艺的发展催生了更先进的一次性生物反应器的生产，这些生物反应器具有更高水平的性能、可靠性和可扩展性。例如，聚乙烯和聚丙烯等先进聚合物的使用导致了一次性生物反应器的生产，这些生物反应器更耐用，能耐受更广泛的化学品和温度范围。此外，自动化和过程控制的进步导致生物加工操作更加精确和高效，进一步推动了对一次性生物反应器的需求。自动化技术有助于降低污染风险，最大限度地减少操作员错误，并提高生物加工操作的速度和准确性。更复杂的传感器和分析工具的发展使得可以对生物过程进行更详细的监测和控制。这提高了工艺效率、提高了产品产量并降低了成本。随着研究不断发现生物製药的新应用和用途，对更先进的一次性生物反应器的需求预计将会增长。这些进步将继续推动全球一次性生物反应器市场的创新和增长，提供更高效、更具成本效益的生物加工解决方案，以满足生物製药行业的需求。

生物製药行业的资金不断增加

不断增长的政府支持对全球一次性生物反应器市场的增长产生重大影响。世界各国政府越来越认识到生物製药行业的重要性以及这些生物加工技术的作用，例如一次性生物反应器，在新药等生物製药产品的开发和生产中发挥着重要作用。各国政府以多种方式为一次性生物反应器市场的增长提供支持，包括研发资金、税收优惠和监管支持，这将在预测期内进一步推动市场的增长。例如，在美国，美国国立卫生研究院 (NIH) 和生物医学高级研究与发展局 (BARDA) 为新型生物加工技术（包括一次性生物反应器）的研发提供资金。政府在监管生物製药产品的安全性和有效性方面发挥着至关重要的作用，用于生产这些产品的技术将加速其在生物製药製造中的采用，并推动市场多年来的增长。

近期发展

  • 2022 年 3 月，Sartorius AG 宣布推出新型一次性生物反应器系统 BIOSTAT STR (R) 1000。该系统旨在满足大规模生物加工不断增长的需求，并提供先进的自动化和控制功能。
  • 2022 年 1 月，GE Healthcare Life Sciences 宣布收购创新生物加工解决方案提供商 Univercells Technologies。此次收购预计将扩大 GE Healthcare 在一次性生物反应器市场的产品范围，并增强其在生物製药行业的地位。
  • 2021 年 12 月，赛默飞世尔科技宣布推出新型一次性生物反应器 HyPerforma (TM) 一次性生物反应器 (SUB)。该系统旨在提供高产量和工艺效率，并提高灵活性和可扩展性。
  • 2021 年 11 月，默克公司宣布扩建其在美国的一次性製造工厂。此次扩建预计将提高默克生产一次性生物反应器的能力，并支持对生物製药产品不断增长的需求。
  • 2021 年 9 月，颇尔公司宣布推出新型一次性生物反应器 Allegro (TM) STR 400。该系统提供先进的自动化和控制功能，并提高了生物加工操作的灵活性和可扩展性。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球一次性生物反应器市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（一次性生物反应器系统、一次性介质袋、一次性过滤组件、其他产品）
    • 按类型（搅拌罐 SUB、波诱导 SUB、鼓泡塔 SUB、其他 SUB）
    • 按细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
    • 按分子（单克隆抗体、疫苗、基因修饰细胞、干细胞、其他分子）
    • 按应用（研究与开发、生物生产）
    • 按用途（实验室规模生产、中试规模生产、大规模生产）
    • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按产品分类
    • 按类型
    • 按电池类型
    • 按分子
    • 按应用
    • 按用途
    • 按最终用户
    • 按地区

第 6 章：北美一次性生物反应器市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（一次性生物反应器系统、一次性介质袋、一次性过滤组件、其他产品）
    • 按类型（搅拌罐 SUB、波诱导 SUB、鼓泡塔 SUB、其他 SUB）
    • 按细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
    • 按分子（单克隆抗体、疫苗、基因修饰细胞、干细胞、其他分子）
    • 按应用（研究与开发、生物生产）
    • 按用途（实验室规模生产、中试规模生产、大规模生产）
    • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲一次性生物反应器市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（一次性生物反应器系统、一次性介质袋、一次性过滤组件、其他产品）
    • 按类型（搅拌罐 SUB、波诱导 SUB、鼓泡塔 SUB、其他 SUB）
    • 按细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
    • 按分子（单克隆抗体、疫苗、基因修饰细胞、干细胞、其他分子）
    • 按应用（研究与开发、生物生产）
    • 按用途（实验室规模生产、中试规模生产、大规模生产）
    • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太地区一次性生物反应器市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（一次性生物反应器系统、一次性介质袋、一次性过滤组件、其他产品）
    • 按类型（搅拌罐 SUB、波诱导 SUB、鼓泡塔 SUB、其他 SUB）
    • 按细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
    • 按分子（单克隆抗体、疫苗、基因修饰细胞、干细胞、其他分子）
    • 按应用（研究与开发、生物生产）
    • 按用途（实验室规模生产、中试规模生产、大规模生产）
    • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章：南美一次性生物反应器市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（一次性生物反应器系统、一次性介质袋、一次性过滤组件、其他产品）
    • 按类型（搅拌罐 SUB、波诱导 SUB、鼓泡塔 SUB、其他 SUB）
    • 按细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
    • 按分子（单克隆抗体、疫苗、基因修饰细胞、干细胞、其他分子）
    • 按应用（研究与开发、生物生产）
    • 按用途（实验室规模生产、中试规模生产、大规模生产）
    • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲一次性生物反应器市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 副产品（一次性生物反应器系统、一次性介质袋、一次性过滤组件、其他产品）
    • 按类型（搅拌罐 SUB、波诱导 SUB、鼓泡塔 SUB、其他 SUB）
    • 按细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
    • 按分子（单克隆抗体、疫苗、基因修饰细胞、干细胞、其他分子）
    • 按应用（研究与开发、生物生产）
    • 按用途（实验室规模生产、中试规模生产、大规模生产）
    • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
    • 按国家/地区
  • MEA：国家分析
    • 南非一次性生物反应器
    • 沙特阿拉伯一次性生物反应器
    • 阿联酋一次性生物反应器

第 11 章：市场动态

  • 司机
    • 对实验室自动化活动的需求不断增长
    • 生物样本库越来越多地采用实验室信息学
    • 越来越多地引入技术先进的软件服务
  • 挑战
    • 缺乏实验室信息学集成标准
    • 严格的规定

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球一次性生物反应器市场：SWOT 分析

第 14 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • ABEC,INC.
    • Able Corporation & Biott Corporation.
    • BBI-Biotech Gmbh.
    • Cellexus Biosystems PLC.
    • Celltainer Biotech BV.
    • Danaher Corp.
    • Distek Inc.
    • Eppendorf AG.
    • G&G Technologies, Inc.
    • Getinge AB.

第 16 章：战略建议

简介目录
Product Code: 15169

Global Single-Use Bioreactors Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing research and development (R&D) activities, collaborations, and strategic partnerships, along with soaring demand for new vaccines, therapeutics, and rising chronic and infectious diseases. Also, the growing development of monoclonal antibodies is anticipated to create demand for SUBs used for manufacturing facilities, thereby expected to drive segment growth. In January 2022, HaemaLogiX Ltd (HaemaLogiX) and Lonza entered into an agreement for manufacturing the next clinical batch (cGMP) of HaemaLogiX's lead multiple myeloma drug candidate and KappaMab, which is a monoclonal antibody and binds to a cell surface target which is called as kappa myeloma antigen (KMA) and found on myeloma cancer cells and not on normal plasma cells.

Increasing demand for biopharmaceuticals

Biopharmaceuticals play a significant role in driving the growth of the Global Single-Use Bioreactors Market. Biopharmaceuticals are drugs and vaccines that are produced using living organisms such as bacteria, yeast, or mammalian cells. Single-use bioreactors are widely used in the production of these biopharmaceuticals due to their cost-effectiveness, efficiency, and flexibility. The increasing demand for biopharmaceuticals is one of the key drivers of the Single-Use Bioreactors Market. Biopharmaceuticals have become an important component of modern medicine, as they offer targeted and personalized treatments for various diseases. The Global Biopharmaceuticals Market is expected to grow at a significant rate, driven by factors such as an aging population, increasing prevalence of chronic diseases, and the need for innovative and targeted therapies. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors, such as lower capital and operational costs, reduced risk of cross-contamination, and greater flexibility. These advantages make single-use bioreactors an attractive option to produce biopharmaceuticals, particularly for smaller batches and clinical trials. The biopharmaceutical industry is adopting new bioprocessing technologies, such as high-density cell cultures and continuous manufacturing, which require flexible and efficient bioreactors. Single-use bioreactors can adapt to changing process requirements, making them ideal for these new technologies.

Cost-effectiveness and efficiency of single-use bioreactors

Cost-effectiveness and efficiency are key factors driving the growth of the Global Single-Use Bioreactors Market. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of cost and efficiency. One of the primary advantages of single-use bioreactors is their lower capital cost. Traditional stainless-steel bioreactors require significant upfront capital investments in infrastructure and equipment, whereas single-use bioreactors require much less capital investment. This makes single-use bioreactors an attractive option for small and medium-sized companies, as well as for research and development purposes to lower capital costs; single-use bioreactors offer lower operational costs compared to traditional bioreactors. The use of single-use components, such as bags, filters, and sensors, reduces the need for cleaning and sterilization, which can be time-consuming and costly. This reduces the risk of cross-contamination between batches, ensuring higher quality and more consistent products. Single-use bioreactors offer greater flexibility, which can lead to increased efficiency. They can be quickly and easily set up, allowing for faster product turnaround times. Single-use bioreactors are more adaptable to changes in process requirements, making them ideal for research and development, as well as for small-scale production.

Growing focus on personalized medicine

Personalized medicine is a major driver of the growth of the Global Single-Use Bioreactors Market. Personalized medicine is an approach to healthcare that considers individual variability in genes, environment, and lifestyle when designing treatment plans for patients. This approach requires the production of targeted and individualized therapies, which can be achieved using biopharmaceuticals and single-use bioreactors. The use of single-use bioreactors allows for more efficient and cost-effective production of biopharmaceuticals, which are the foundation of personalized medicine. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of flexibility, efficiency, and scalability, making them ideal for producing targeted and personalized therapies.

Single-use bioreactors are particularly well-suited to produce smaller batches of biopharmaceuticals, which are often required for personalized medicine. They are ideal for research and development purposes, as they allow for rapid and cost-effective testing of new therapies. The demand for personalized medicine is expected to grow in the coming years, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advances in genomics and proteomics. This growth is expected to fuel the demand for biopharmaceuticals and single-use bioreactors, as personalized medicine requires the production of targeted and individualized therapies.

Advancements in bioprocessing technology

Advancements in technology and research are key drivers of the growth of the Global Single-Use Bioreactors Market. As the biopharmaceutical industry continues to evolve and expand, there is a growing need for more efficient and cost-effective bioprocessing solutions. The development of new materials and manufacturing processes has led to the production of more advanced single-use bioreactors that offer higher levels of performance, reliability, and scalability. For example, the use of advanced polymers such as polyethylene and polypropylene has led to the production of single-use bioreactors that are more durable and resistant to a wider range of chemicals and temperature ranges. In addition, advancements in automation and process control have led to more precise and efficient bioprocessing operations, further driving the demand for single-use bioreactors. Automation technology can help to reduce the risk of contamination, minimize operator error, and increase the speed and accuracy of bioprocessing operations. The development of more sophisticated sensors and analytical tools has allowed for more detailed monitoring and control of bioprocesses. This has led to improved process efficiency, higher product yields, and reduced costs. As research continues to uncover new applications and uses for biopharmaceuticals, the demand for more advanced single-use bioreactors is expected to grow. These advancements will continue to drive innovation and growth in the Global Single-Use Bioreactors Market, providing more efficient and cost-effective bioprocessing solutions to meet the needs of the biopharmaceutical industry.

Growing funding for the biopharmaceutical industry

Growing government support plays a significant impact in the growth of the Global Single-Use Bioreactors Market. Governments around the world are increasingly recognizing the importance of the biopharmaceutical industry and the role of these bioprocessing technologies, such as single-use bioreactors, play an important role in the development and production of biopharmaceutical products such as novel drugs. Governments provide support for the growth of the single-use bioreactors market in several ways, including funding for research and development, tax incentives, and regulatory support which will further drive the growth of the market during the forecast period. For example, in the United States, the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) provide funding for research and development of new bioprocessing technologies, including single-use bioreactors. Governments play a crucial role in regulating the safety and efficacy of biopharmaceutical products, and the technologies used to produce them will accelerate their adoption in biopharmaceutical manufacturing and propel the growth of the market over the years.

Recent Development

  • In March 2022, Sartorius AG announced the launch of its new single-use bioreactor system, BIOSTAT STR® 1000. The system was designed to meet the growing demand for large-scale bioprocessing and offers advanced automation and control features.
  • In January 2022, GE Healthcare Life Sciences announced the acquisition of Univercells Technologies, a provider of innovative bioprocessing solutions. The acquisition is expected to expand GE Healthcare's offerings in the single-use bioreactors market and enhance its position in the biopharmaceutical industry.
  • In December 2021, Thermo Fisher Scientific announced the launch of its new single-use bioreactor, the HyPerforma™ Single-Use Bioreactor (SUB). The system is designed to provide high yields and process efficiencies with improved flexibility and scalability.
  • In November 2021, Merck KGaA announced the expansion of its single-use manufacturing facility in the United States. The expansion is expected to increase Merck's capacity to produce single-use bioreactors and support the growing demand for biopharmaceutical products.
  • In September 2021, Pall Corporation announced the launch of its new single-use bioreactor, the Allegro™ STR 400. The system offers advanced automation and control features, as well as improved flexibility and scalability for bioprocessing operations.

Market Segmentation

Global Single-Use Bioreactors market can be segmented by product, type, type of cell, molecule, application, usage, end user, and by region. Based on product, the market can be segmented into Single-use bioreactor systems, Single-use media bags, Single-use filtration assemblies, and other products. Based on type, the market can be segmented into Stirred tank SUB, Wave induced SUB, Bubble Column SUB, and Other SUB. Based on the type of cell, the market can be differentiated into Mammalian Cell, Bacterial Cell, Yeast Cell, and Other Cells. Based on molecules, the market can be grouped into Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, and Other molecules. Based on application, the market can be segmented into Research and Development, Bioproduction. Based on usage, the market can be differentiated into Lab scale production, Pilot scale production, and large scale production. Based on end users, the market can be grouped into Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, and Academic and Research Institutes.

Market Players

ABEC, INC., Able Corporation & Biott Corporation., BBI-Biotech Gmbh., Cellexus Biosystems PLC., Celltainer Biotech BV., Danaher Corp., Distek Inc., Eppendorf AG., G&G Technologies, Inc., Getinge AB are some of the leading players operating in the Global Single-Use Bioreactors Market.

Report Scope:

In this report, the Global Single-Use Bioreactors market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Single-Use Bioreactors Market, By Product:

  • Single-use bioreactor systems
  • Single use media bags
  • Single use filtration assemblies
  • other products

Single-Use Bioreactors Market, By Type:

  • Stirred tank SUB.
  • Wave-induced SUB.
  • Bubble Column SUB
  • Other SUB

Single-Use Bioreactors Market, By Type of Cell:

  • Mammalian Cell
  • Bacterial Cell
  • Yeast Cell
  • Other Cells

Single-Use Bioreactors Market, By Molecule:

  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other molecules

Single-Use Bioreactors Market, By Application:

  • Research and Development
  • Bioproduction

Single-Use Bioreactors Market, By Usage:

  • Lab-scale production
  • Pilot-scale production
  • large scale production

Single-Use Bioreactors Market, By End User:

  • Pharmaceutical and Biopharmaceutical companies
  • CROSs & CMOS
  • Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 5.2.5. By Application (Research and Development, Bioproduction)
    • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.9. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product
    • 5.3.2 By Type
    • 5.3.3 By Type of Cell
    • 5.3.4 By Molecule
    • 5.3.5 By Application
    • 5.3.6 By Usage
    • 5.3.7 By End User
    • 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 6.2.5. By Application (Research and Development, Bioproduction)
    • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 6.2.8. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Single-Use Bioreactors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Type of Cell
        • 6.3.1.2.4. By Molecule
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By Usage
        • 6.3.1.2.7. By End User
    • 6.3.2. Canada Single-Use Bioreactors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Type of Cell
        • 6.3.2.2.4. By Molecule
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By Usage
        • 6.3.2.2.7. By End User
    • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Type of Cell
        • 6.3.3.2.4. By Molecule
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By Usage
        • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 7.2.5. By Application (Research and Development, Bioproduction)
    • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 7.2.8. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Single-Use Bioreactors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Type of Cell
        • 7.3.1.2.4. By Molecule
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By Usage
        • 7.3.1.2.7. By End User
    • 7.3.2. Germany Single-Use Bioreactors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Type of Cell
        • 7.3.2.2.4. By Molecule
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By Usage
        • 7.3.2.2.7. By End User
    • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Type of Cell
        • 7.3.3.2.4. By Molecule
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By Usage
        • 7.3.3.2.7. By End User
    • 7.3.4. Italy Single-Use Bioreactors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Type of Cell
        • 7.3.4.2.4. By Molecule
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By Usage
        • 7.3.4.2.7. By End User
    • 7.3.5. Spain Single-Use Bioreactors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Type of Cell
        • 7.3.5.2.4. By Molecule
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By Usage
        • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 8.2.5. By Application (Research and Development, Bioproduction)
    • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 8.2.8. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Single-Use Bioreactors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Type of Cell
        • 8.3.1.2.4. By Molecule
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By Usage
        • 8.3.1.2.7. By End User
    • 8.3.2. India Single-Use Bioreactors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Type of Cell
        • 8.3.2.2.4. By Molecule
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By Usage
        • 8.3.2.2.7. By End User
    • 8.3.3. Japan Single-Use Bioreactors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Type of Cell
        • 8.3.3.2.4. By Molecule
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By Usage
        • 8.3.3.2.7. By End User
    • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Type of Cell
        • 8.3.4.2.4. By Molecule
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By Usage
        • 8.3.4.2.7. By End User
    • 8.3.5. Australia Single-Use Bioreactors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Type of Cell
        • 8.3.5.2.4. By Molecule
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By Usage
        • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 9.2.5. By Application (Research and Development, Bioproduction)
    • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 9.2.8. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Type of Cell
        • 9.3.1.2.4. By Molecule
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By Usage
        • 9.3.1.2.7. By End User
    • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Type of Cell
        • 9.3.2.2.4. By Molecule
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By Usage
        • 9.3.2.2.7. By End User
    • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Type of Cell
        • 9.3.3.2.4. By Molecule
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By Usage
        • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 10.2.5. By Application (Research and Development, Bioproduction)
    • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 10.2.8. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Type of Cell
        • 10.3.1.2.4. By Molecule
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By Usage
        • 10.3.1.2.7. By End User
    • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Type of Cell
        • 10.3.2.2.4. By Molecule
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By Usage
        • 10.3.2.2.7. By End User
    • 10.3.3. UAE Single-Use Bioreactors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Type of Cell
        • 10.3.3.2.4. By Molecule
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By Usage
        • 10.3.3.2.7. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing demand for lab automation activities
    • 11.1.2 Growing adoption of lab informatics by biobanks
    • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
    • 11.2.1 Lack of integration standards for laboratory informatics
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 ABEC,INC.
    • 15.6.2 Able Corporation & Biott Corporation.
    • 15.6.3 BBI-Biotech Gmbh.
    • 15.6.4 Cellexus Biosystems PLC.
    • 15.6.5 Celltainer Biotech BV.
    • 15.6.6 Danaher Corp.
    • 15.6.7 Distek Inc.
    • 15.6.8 Eppendorf AG.
    • 15.6.9 G&G Technologies, Inc.
    • 15.6.10 Getinge AB.

16. Strategic Recommendations